---
figid: PMC6170174__JEM_20180483_Fig8
figlink: /pmc/articles/PMC6170174/figure/fig8/
number: F8
caption: Model of the role of Piezo1 and Gq/G11 proteins in endothelial response to
  different flow patterns. (A and B) Laminar flow (A) and disturbed flow (B) activate
  the same initial signaling processes involving the mechanosensitive cation channel
  Piezo1 and the purinergic receptor P2Y2, as well as Gq/G11-mediated signaling and
  activation of the mechanosignaling complex consisting of PECAM-1, VE-cadherin, and
  VEGFR2. In cells exposed to laminar flow, integrins are not activated and this initial
  signal transduction pathway promotes atheroprotective signaling including activation
  of eNOS through PI-3-kinase and AKT. Through incompletely understood pathways, eNOS
  is also activated by cAMP acting through protein kinase A (PKA). In cells exposed
  to disturbed flow, activation of the initial signaling pathway results in integrin
  activation, which promotes via focal adhesion kinase (FAK) NF-κB activation and
  atherogenic signaling, as well as reduced eNOS activation by promoting cAMP degradation
  via activation of phosphodiesterase 4D (PDE4D).
pmcid: PMC6170174
papertitle: Piezo1 and Gq/G11 promote endothelial inflammation depending on flow pattern
  and integrin activation.
reftext: Julián Albarrán-Juárez, et al. J Exp Med. 2018 Oct 1;215(10):2655-2672.
pmc_ranked_result_index: '27753'
pathway_score: 0.9121733
filename: JEM_20180483_Fig8.jpg
figtitle: The role of Piezo1 and Gq/G11 proteins in endothelial response to different
  flow patterns
year: '2018'
organisms:
- Homo sapiens
ndex: f4acd692-df10-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6170174__JEM_20180483_Fig8.html
  '@type': Dataset
  description: Model of the role of Piezo1 and Gq/G11 proteins in endothelial response
    to different flow patterns. (A and B) Laminar flow (A) and disturbed flow (B)
    activate the same initial signaling processes involving the mechanosensitive cation
    channel Piezo1 and the purinergic receptor P2Y2, as well as Gq/G11-mediated signaling
    and activation of the mechanosignaling complex consisting of PECAM-1, VE-cadherin,
    and VEGFR2. In cells exposed to laminar flow, integrins are not activated and
    this initial signal transduction pathway promotes atheroprotective signaling including
    activation of eNOS through PI-3-kinase and AKT. Through incompletely understood
    pathways, eNOS is also activated by cAMP acting through protein kinase A (PKA).
    In cells exposed to disturbed flow, activation of the initial signaling pathway
    results in integrin activation, which promotes via focal adhesion kinase (FAK)
    NF-κB activation and atherogenic signaling, as well as reduced eNOS activation
    by promoting cAMP degradation via activation of phosphodiesterase 4D (PDE4D).
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PRKACG
  - PRKACB
  - GNA11
  - PRKAR1A
  - PRKACA
  - GNAI2
  - GNAI3
  - GNAL
  - CHUK
  - CDH5
  - PIEZO1
  - KDR
  - AKT3
  - MFAP1
  - PRKAR1B
  - PRKAR2A
  - GNA15
  - GNAI1
  - REL
  - RELA
  - RELB
  - PDE4D
  - PECAM1
  - AKT1
  - GNAS
  - GNAT1
  - GNAT2
  - NOS3
  - PTK2
  - GNAT3
  - NFKB1
  - NFKB2
  - PLCB1
  - PLCB2
  - PLCB4
  - GNAO1
  - GNAQ
  - IKBKB
  - AKT2
  - PRKAR2B
  - GNAZ
  - STOML3
  - IKBKG
  - GNA14
  - PLCB3
  - SRC
  - AMP
  - Cancer
genes:
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACG
  entrez: '5568'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACB
  entrez: '5567'
- word: Ga/11
  symbol: Galpha
  source: bioentities_symbol
  hgnc_symbol: GNA11
  entrez: '2767'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR1A
  entrez: '5573'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACA
  entrez: '5566'
- word: Ga/11
  symbol: Galpha
  source: bioentities_symbol
  hgnc_symbol: GNAI2
  entrez: '2771'
- word: Ga/11
  symbol: Galpha
  source: bioentities_symbol
  hgnc_symbol: GNAI3
  entrez: '2773'
- word: Ga/11
  symbol: Galpha
  source: bioentities_symbol
  hgnc_symbol: GNAL
  entrez: '2774'
- word: IKK
  symbol: IKK
  source: bioentities_symbol
  hgnc_symbol: CHUK
  entrez: '1147'
- word: VE-cadherin
  symbol: CDH5
  source: hgnc_symbol
  hgnc_symbol: CDH5
  entrez: '1003'
- word: Piezo1
  symbol: PIEZO1
  source: hgnc_symbol
  hgnc_symbol: PIEZO1
  entrez: '9780'
- word: VEGFR2
  symbol: VEGFR2
  source: hgnc_alias_symbol
  hgnc_symbol: KDR
  entrez: '3791'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: AMP
  symbol: AMP
  source: hgnc_alias_symbol
  hgnc_symbol: MFAP1
  entrez: '4236'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR1B
  entrez: '5575'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR2A
  entrez: '5576'
- word: Ga/11
  symbol: Galpha
  source: bioentities_symbol
  hgnc_symbol: GNA15
  entrez: '2769'
- word: Ga/11
  symbol: Galpha
  source: bioentities_symbol
  hgnc_symbol: GNAI1
  entrez: '2770'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: REL
  entrez: '5966'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELA
  entrez: '5970'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELB
  entrez: '5971'
- word: PDE4D
  symbol: PDE4D
  source: hgnc_symbol
  hgnc_symbol: PDE4D
  entrez: '5144'
- word: PECAM-1
  symbol: PECAM1
  source: hgnc_symbol
  hgnc_symbol: PECAM1
  entrez: '5175'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: Ga/11
  symbol: Galpha
  source: bioentities_symbol
  hgnc_symbol: GNAS
  entrez: '2778'
- word: Ga/11
  symbol: Galpha
  source: bioentities_symbol
  hgnc_symbol: GNAT1
  entrez: '2779'
- word: Ga/11
  symbol: Galpha
  source: bioentities_symbol
  hgnc_symbol: GNAT2
  entrez: '2780'
- word: ENOS+
  symbol: eNOS
  source: hgnc_alias_symbol
  hgnc_symbol: NOS3
  entrez: '4846'
- word: FAK
  symbol: FAK
  source: hgnc_alias_symbol
  hgnc_symbol: PTK2
  entrez: '5747'
- word: Ga/11
  symbol: Galpha
  source: bioentities_symbol
  hgnc_symbol: GNAT3
  entrez: '346562'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB2
  entrez: '4791'
- word: PLC-B
  symbol: PLCB
  source: bioentities_symbol
  hgnc_symbol: PLCB1
  entrez: '23236'
- word: PLC-B
  symbol: PLCB
  source: bioentities_symbol
  hgnc_symbol: PLCB2
  entrez: '5330'
- word: PLC-B
  symbol: PLCB
  source: bioentities_symbol
  hgnc_symbol: PLCB4
  entrez: '5332'
- word: Ga/11
  symbol: Galpha
  source: bioentities_symbol
  hgnc_symbol: GNAO1
  entrez: '2775'
- word: Ga/11
  symbol: Galpha
  source: bioentities_symbol
  hgnc_symbol: GNAQ
  entrez: '2776'
- word: IKK
  symbol: IKK
  source: bioentities_symbol
  hgnc_symbol: IKBKB
  entrez: '3551'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR2B
  entrez: '5577'
- word: Ga/11
  symbol: Galpha
  source: bioentities_symbol
  hgnc_symbol: GNAZ
  entrez: '2781'
- word: Sro
  symbol: SRO
  source: hgnc_alias_symbol
  hgnc_symbol: STOML3
  entrez: '161003'
- word: IKK
  symbol: IKK
  source: bioentities_symbol
  hgnc_symbol: IKBKG
  entrez: '8517'
- word: Ga/11
  symbol: Galpha
  source: bioentities_symbol
  hgnc_symbol: GNA14
  entrez: '9630'
- word: PLC-B
  symbol: PLCB
  source: bioentities_symbol
  hgnc_symbol: PLCB3
  entrez: '5331'
- word: Src
  symbol: SRC
  source: hgnc_symbol
  hgnc_symbol: SRC
  entrez: '6714'
chemicals:
- word: AMP
  source: MESH
  identifier: D000249
diseases:
- word: Cancer
  source: ''
  identifier: ''
figid_alias: PMC6170174__F8
redirect_from: /figures/PMC6170174__F8
figtype: Figure
---
